Camptothecin and mitomycin combination chemotherapy on ovarian clear cell carcinoma with multiple systemic metastases

被引：0
|
作者：
Tanaka, T [1 ]
Umesaki, N [1 ]
Ogita, S [1 ]
机构：
[1] Osaka City Univ, Sch Med, Dept Obstet & Gynecol, Abeno Ku, Osaka 5458585, Japan
来源：
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 2000年 / 21卷 / 04期
关键词：
camptothecin; mitomycin; clear cell carcinoma; ovary; chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ovarian clear cell carcinoma is known for decreased responsiveness to most anticancer drugs, and the prognosis of patients with ovarian clear cell tumors is very poor. We report such a patient with multiple systemic metastases who showed a complete response to combined camptothecin and mitomycin chemotherapy. During therapy, clinical drug-resistance was observed transiently, but response was restored by intermittent administrations of camptothecin. Such combination chemotherapy may be a useful alternative regimen for advanced and/or metastatic ovarian clear cell carcinoma.
引用
收藏
页码：377 / 379
页数：3
相关论文
共 50 条
  • [41] Napsin A as a marker of clear cell ovarian carcinoma
    Skirnisdottir, Ingiridur
    Bjersand, Kathrine
    Akerud, Helena
    Seidal, Tomas
    BMC CANCER, 2013, 13
  • [42] Chromosomal abnormalities in ovarian clear cell carcinoma
    Dent, J
    Perren, T
    Wilkinson, N
    Richmond, I
    Markham, A
    Bell, S
    BRITISH JOURNAL OF CANCER, 2001, 85 : 73 - 73
  • [43] Ovarian Clear Cell Carcinoma in Cowden Syndrome
    Yauy, Kevin
    Imbert-Bouteille, Marion
    Bubien, Virginie
    Lindet-Bourgeois, Clothilde
    Rathat, Gauthier
    Perrochia, Helene
    MacGrogan, Gaetan
    Longy, Michel
    Bessis, Didier
    Tinat, Julie
    Baert-Desurmont, Stephanie
    Blanluet, Maud
    Vande Perre, Pierre
    Baudry, Karen
    Pujol, Pascal
    Corsini, Carole
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (01): : 7 - 11
  • [44] A CLEARER VIEW ON OVARIAN CLEAR CELL CARCINOMA
    De Pauw, Aglaja
    Naert, Eline
    Van de Vijver, Koen
    Philippe, Tummers
    Vandecasteele, Katrien
    Denys, Hannelore
    ACTA CLINICA BELGICA, 2022, 77 (04) : 792 - 804
  • [45] Molecular pathogenesis of ovarian clear cell carcinoma
    Gounaris, Ioannis
    Brenton, James D.
    FUTURE ONCOLOGY, 2015, 11 (09) : 1389 - 1405
  • [46] Expression of podoplanin in ovarian clear cell carcinoma
    Kotarski, Jozef
    Marzec-Kotarska, Barbara
    Szumilo, Justyna
    Klepacz, Robert
    Cybulski, Marek
    Sobstyl, Malgorzata
    Bednarek, Wieslawa
    GINEKOLOGIA POLSKA, 2011, 82 (05) : 350 - 353
  • [47] New therapies for clear cell ovarian carcinoma
    Stewart, James
    Cunningham, Niamh
    Banerjee, Susana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 385 - 393
  • [48] The target therapy of ovarian clear cell carcinoma
    Jin, Ying
    Li, Yan
    Pan, Lingya
    ONCOTARGETS AND THERAPY, 2014, 7 : 1647 - 1652
  • [49] Napsin A as a marker of clear cell ovarian carcinoma
    Ingiridur Skirnisdottir
    Kathrine Bjersand
    Helena Åkerud
    Tomas Seidal
    BMC Cancer, 13
  • [50] TOTAL LUNG IRRADIATION AND COMBINATION CHEMOTHERAPY IN PULMONARY METASTASES FROM NON-OVARIAN GYNECOLOGIC CARCINOMA
    MUNDIA, AG
    CORTES, EP
    AKBIYIK, N
    CHEN, S
    KRUMHOLZ, B
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1978, 117 (04): : 160 - 160
12345